CoChat

Proteome- and Transcriptome-Driven Reconstruction of the Human Myocyte Metabolic Network and Its Use for Identification of Markers for Diabetes

Open access
Väremo, Leif, Scheele, Camilla, Broholm, Christa, Mardinoglu, Adil, Kampf, Caroline, Asplund, Anna, Nookaew, Intawat, Uhlén, Mathias, Pedersen, Bente Klarlund, Nielsen, Jens · 2015 · Cell Reports
Cited by 116

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Skeletal myocytes are metabolically active and susceptible to insulin resistance and are thus implicated in type 2 diabetes (T2D). This complex disease involves systemic metabolic changes, and their elucidation at the systems level requires genome-wide data and biological networks. Genome-scale metabolic models (GEMs) provide a network context for the integration of high-throughput data. We generated myocyte-specific RNA-sequencing data and investigated their correlation with proteome data. These data were then used to reconstruct a comprehensive myocyte GEM. Next, we performed a meta-analysis of six studies comparing muscle transcription in T2D versus healthy subjects. Transcriptional changes were mapped on the myocyte GEM, revealing extensive transcriptional regulation in T2D, particularly around pyruvate oxidation, branched-chain amino acid catabolism, and tetrahydrofolate metabolism, connected through the downregulated dihydrolipoamide dehydrogenase. Strikingly, the gene signature underlying this metabolic regulation successfully classifies the disease state of individual samples, suggesting that regulation of these pathways is a ubiquitous feature of myocytes in response to T2D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2015.04.010

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. Agren, 2012, Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT, PLoS Comput. Biol., 8, e1002518, 10.1371/journal.pcbi.1002518 · DOI · Paper page
  2. Agren, 2013, The RAVEN toolbox and its use for generating a genome-scale metabolic model for Penicillium chrysogenum, PLoS Comput. Biol., 9, e1002980, 10.1371/journal.pcbi.1002980 · DOI · Paper page
  3. Agren, 2014, Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling, Mol. Syst. Biol., 10, 721, 10.1002/msb.145122 · DOI · Paper page
  4. Anders, 2015, HTSeq—a Python framework to work with high-throughput sequencing data, Bioinformatics, 31, 166, 10.1093/bioinformatics/btu638 · DOI · Paper page
  5. Bergström, 1975, Percutaneous needle biopsy of skeletal muscle in physiological and clinical research, Scand. J. Clin. Lab. Invest., 35, 609, 10.3109/00365517509095787 · DOI · Paper page
  6. Bordbar, 2011, A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology, BMC Syst. Biol., 5, 180, 10.1186/1752-0509-5-180 · DOI · Paper page
  7. Bordbar, 2014, Constraint-based models predict metabolic and associated cellular functions, Nat. Rev. Genet., 15, 107, 10.1038/nrg3643 · DOI · Paper page
  8. Boushel, 2007, Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle, Diabetologia, 50, 790, 10.1007/s00125-007-0594-3 · DOI · Paper page
  9. Broholm, 2012, Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes, Am. J. Physiol. Endocrinol. Metab., 303, E283, 10.1152/ajpendo.00586.2011 · DOI
  10. Choi, 2003, Combining multiple microarray studies and modeling interstudy variation, Bioinformatics, 19, i84, 10.1093/bioinformatics/btg1010 · DOI · Paper page
  11. Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
  12. Gallagher, 2010, Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes, Genome Med., 2, 9, 10.1186/gm130 · DOI · Paper page
  13. Green, 2011, Elevated NF-κB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase, Diabetes, 60, 2810, 10.2337/db11-0263 · DOI · Paper page
  14. Jin, 2011, Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance, J. Clin. Invest., 121, 918, 10.1172/JCI41940 · DOI · Paper page
  15. Kimura, 2013, Histidine augments the suppression of hepatic glucose production by central insulin action, Diabetes, 62, 2266, 10.2337/db12-1701 · DOI · Paper page
  16. Lee, 2005, Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation, Eur. J. Pharmacol., 513, 145, 10.1016/j.ejphar.2005.02.010 · DOI · Paper page
  17. Mardinoglu, 2013, Integration of clinical data with a genome-scale metabolic model of the human adipocyte, Mol. Syst. Biol., 9, 649, 10.1038/msb.2013.5 · DOI · Paper page
  18. Mardinoglu, 2013, Genome-scale modeling of human metabolism - a systems biology approach, Biotechnol. J., 8, 985, 10.1002/biot.201200275 · DOI
  19. Mardinoglu, 2014, Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease, Nat. Commun., 5, 3083, 10.1038/ncomms4083 · DOI · Paper page
  20. Møller, 2014, Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Caucasians, Diabetes Care, 37, 796, 10.2337/dc13-0598 · DOI
  21. Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet., 34, 267, 10.1038/ng1180 · DOI · Paper page
  22. Patil, 2005, Uncovering transcriptional regulation of metabolism by using metabolic network topology, Proc. Natl. Acad. Sci. USA, 102, 2685, 10.1073/pnas.0406811102 · DOI · Paper page
  23. Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. USA, 100, 8466, 10.1073/pnas.1032913100 · DOI · Paper page
  24. Petropoulos, 2014, Gestational diabetes alters offspring DNA methylation profiles in human and rat: identification of key pathways involved in endocrine system disorders, insulin signaling, diabetes signaling and IL-K signaling, Endocrinology
  25. Pihlajamäki, 2011, Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis, Cell Metab., 14, 208, 10.1016/j.cmet.2011.06.007 · DOI · Paper page
  26. Ramakrishnan, 2009, Integrating shotgun proteomics and mRNA expression data to improve protein identification, Bioinformatics, 25, 1397, 10.1093/bioinformatics/btp168 · DOI · Paper page
  27. Ramasamy, 2008, Key issues in conducting a meta-analysis of gene expression microarray datasets, PLoS Med., 5, e184, 10.1371/journal.pmed.0050184 · DOI · Paper page
  28. Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
  29. Rustici, 2013, ArrayExpress update—trends in database growth and links to data analysis tools, Nucleic Acids Res., 41, D987, 10.1093/nar/gks1174 · DOI · Paper page
  30. Scheele, 2012, Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6, PLoS ONE, 7, e39657, 10.1371/journal.pone.0039657 · DOI
  31. Sears, 2009, Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization, Proc. Natl. Acad. Sci. USA, 106, 18745, 10.1073/pnas.0903032106 · DOI · Paper page
  32. Shin, 2014, Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism, Cell Metab., 20, 898, 10.1016/j.cmet.2014.09.003 · DOI
  33. Stancáková, 2012, Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men, Diabetes, 61, 1895, 10.2337/db11-1378 · DOI · Paper page
  34. Trapnell, 2010, Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation, Nat. Biotechnol., 28, 511, 10.1038/nbt.1621 · DOI · Paper page
  35. Väremo, 2013, Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods, Nucleic Acids Res., 41, 4378, 10.1093/nar/gkt111 · DOI · Paper page
  36. Väremo, 2013, Novel insights into obesity and diabetes through genome-scale metabolic modeling, Front. Physiol., 4, 92, 10.3389/fphys.2013.00092 · DOI
  37. Väremo, 2014, Kiwi: a tool for integration and visualization of network topology and gene-set analysis, BMC Bioinformatics, 15, 408, 10.1186/s12859-014-0408-9 · DOI
  38. Wang, 2012, Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE, BMC Syst. Biol., 6, 153, 10.1186/1752-0509-6-153 · DOI · Paper page

Cited by

See all 116

Metadata

Authors
Väremo, L., Scheele, C., Broholm, C., Mardinoglu, A., Kampf, C., Asplund, A., Nookaew, I., Uhlén, M., Pedersen, B. K., & Nielsen, J.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2015-05
Volume
11
Issue
6
Pages
921-933
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2031367929
Cited by
116
References
21
FWCI
7.20
Type
journal article
Language
en
Update notices
erratum (2016-02-16)
Open access
gold
Licence
Funders
  • Danmarks Grundforskningsfond (DNRF55)
  • Knut och Alice Wallenbergs Stiftelse
  • TrygFonden
  • Novo Nordisk Foundation Center for Basic Metabolic Research
  • Strategiske Forskningsråd (09-067009, 09-075724)
  • Bill and Melinda Gates Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.